These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 38351954)
1. Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records. Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio MP; Wan GJ Ther Clin Risk Manag; 2024; 20():83-94. PubMed ID: 38351954 [TBL] [Abstract][Full Text] [Related]
2. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records. Chopra I; Qin Y; Kranyak J; Gallagher JR; Heap K; Carroll S; Wan GJ Ther Adv Respir Dis; 2019; 13():1753466619888127. PubMed ID: 31722624 [TBL] [Abstract][Full Text] [Related]
3. Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis. Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio MP; Wan GJ J Health Econ Outcomes Res; 2022; 9(1):90-100. PubMed ID: 35529249 [No Abstract] [Full Text] [Related]
4. Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis. Hayes K; Niewoehner J; Rice JB; Downes N; Hagopian E; Ma I; Wan GJ Adv Ther; 2023 Nov; 40(11):4999-5015. PubMed ID: 37728695 [TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis. Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio M; Wan GJ Clinicoecon Outcomes Res; 2023; 15():739-752. PubMed ID: 37868649 [TBL] [Abstract][Full Text] [Related]
6. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients. Baughman RP; Barney JB; O'Hare L; Lower EE Respir Med; 2016 Jan; 110():66-72. PubMed ID: 26626451 [TBL] [Abstract][Full Text] [Related]
7. Response to Acthar Gel in sarcoidosis uveitis: A prospective open label study. Ungprasert P; Lowder C; Sharma S; Ribeiro Neto ML; Baran J; Srivastava SK; Culver DA Respir Med; 2023; 219():107422. PubMed ID: 37827293 [TBL] [Abstract][Full Text] [Related]
8. Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel. Zhou Y; Lower EE; Li H; Baughman RP Respir Med Case Rep; 2016; 17():5-7. PubMed ID: 27222775 [TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus. Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio M; Wan GJ Adv Ther; 2023 Jan; 40(1):194-210. PubMed ID: 36266383 [TBL] [Abstract][Full Text] [Related]
10. Healthcare Costs and Resource Utilization in Patients with Infantile Spasms Treated with H.P. Acthar Gel(®). Gold LS; Schepman PB; Wang WJ; Philbin M; Niewoehner J; Damal K; Hansen RN Adv Ther; 2016 Aug; 33(8):1293-304. PubMed ID: 27324137 [TBL] [Abstract][Full Text] [Related]
11. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review. Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646 [TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
13. Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis. Mirsaeidi M; Baughman RP; Sahoo D; Tarau E Pulm Ther; 2023 Jun; 9(2):237-253. PubMed ID: 37072607 [TBL] [Abstract][Full Text] [Related]
14. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959 [TBL] [Abstract][Full Text] [Related]
15. Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®). Gold LS; Suh K; Schepman PB; Damal K; Hansen RN Adv Ther; 2016 Aug; 33(8):1279-92. PubMed ID: 27312977 [TBL] [Abstract][Full Text] [Related]
16. Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients. Li X; Golubovsky J; Hui-Yuen J; Shah U; Olech E; Lomeo R; Singh V; Busch H; Strandberg MJ; Strandberg K; Horowitz L; Askanase A F1000Res; 2015; 4():1103. PubMed ID: 27158444 [TBL] [Abstract][Full Text] [Related]